FertiProt

Gel Formulation for Fertility Enhancement

Health Tech & Life Sciences
Non Active, Jan 2022 ceased to operate
Mature Modi'in-Maccabim-Re'ut, Israel Founded 2011
Last updated 2026-06-18
Total raised
Stage
Mature
Founded
2011
Headcount
6
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences

About

FertiProt offers an innovative technology based on the evolutionary, chemical, and biological properties of the fertility process. Its product enhances both male and female potency through the addition of formulated proteins, in the form of either a gel or a suppository, to increase the possibility of fertilization. The companys novel formulation and technology has the potential to reduce the need for invasive hormonal-based treatments such as IVF. FertiProts approach is designed to increase the probability of conception for couples with fertility impairment, either by enhancing the efficacy of artificial insemination or through natural intercourse.

Q&A

What is FertiProt's primary business?
FertiProt offers an innovative technology based on the evolutionary, chemical, and biological properties of the fertility process, providing a gel formulation for fertility enhancement.
What is the current status of FertiProt?
FertiProt is currently inactive, having ceased to operate in January 2022.
When was FertiProt founded?
FertiProt was founded in October 2011.
Where is FertiProt headquartered?
FertiProt is headquartered in Modi'in-Maccabim-Re'ut, Center District, Israel.
What is FertiProt's primary sector?
FertiProt's primary sector is Health Tech & Life Sciences.
Does FertiProt hold any patents?
Yes, FertiProt holds 1 patent.
What is the core technology behind FertiProt's product?
FertiProt's technology enhances male and female potency through the addition of formulated proteins, delivered as a gel or suppository, to increase the possibility of fertilization.

Team · 1

Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals
Business model
B2C

Highlights

1 PatentsVerified

Tags

medical-technologiesnon-invasiveparentsgynecologypregnancyfertilitypatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Facebookfacebook.com/dr.ronen.shemesh1

Identifiers & details

Founded2011-10
Employees (exact)6
Status reasonNon Active, Jan 2022 ceased to operate